DK214480A - PROCESS FOR THE PREPARATION OF 2- (PYRIMIDINYLAMINO) -1,3-DIAZA-2-CYCLOALKEN COMPOUNDS OF THEIR TAUTOMER COMPOUNDS AND ACID ADDITION SALTS THEREOF - Google Patents

PROCESS FOR THE PREPARATION OF 2- (PYRIMIDINYLAMINO) -1,3-DIAZA-2-CYCLOALKEN COMPOUNDS OF THEIR TAUTOMER COMPOUNDS AND ACID ADDITION SALTS THEREOF

Info

Publication number
DK214480A
DK214480A DK214480A DK214480A DK214480A DK 214480 A DK214480 A DK 214480A DK 214480 A DK214480 A DK 214480A DK 214480 A DK214480 A DK 214480A DK 214480 A DK214480 A DK 214480A
Authority
DK
Denmark
Prior art keywords
compounds
cycloalken
pyrimidinylamino
diaza
preparation
Prior art date
Application number
DK214480A
Other languages
Danish (da)
Inventor
A Marxer
K Eichenberger
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy filed Critical Ciba Geigy
Publication of DK214480A publication Critical patent/DK214480A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK214480A 1979-05-18 1980-05-16 PROCESS FOR THE PREPARATION OF 2- (PYRIMIDINYLAMINO) -1,3-DIAZA-2-CYCLOALKEN COMPOUNDS OF THEIR TAUTOMER COMPOUNDS AND ACID ADDITION SALTS THEREOF DK214480A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH466979 1979-05-18

Publications (1)

Publication Number Publication Date
DK214480A true DK214480A (en) 1980-11-19

Family

ID=4280399

Family Applications (1)

Application Number Title Priority Date Filing Date
DK214480A DK214480A (en) 1979-05-18 1980-05-16 PROCESS FOR THE PREPARATION OF 2- (PYRIMIDINYLAMINO) -1,3-DIAZA-2-CYCLOALKEN COMPOUNDS OF THEIR TAUTOMER COMPOUNDS AND ACID ADDITION SALTS THEREOF

Country Status (21)

Country Link
EP (1) EP0019811A1 (en)
JP (1) JPS55154971A (en)
KR (1) KR830002757A (en)
AR (1) AR228256A1 (en)
AU (1) AU5848480A (en)
DD (1) DD150609A5 (en)
DK (1) DK214480A (en)
ES (1) ES8104279A1 (en)
FI (1) FI801600A (en)
GB (1) GB2052487B (en)
GR (1) GR68453B (en)
IE (1) IE49803B1 (en)
IL (1) IL60086A (en)
MA (1) MA18829A1 (en)
NO (1) NO801469L (en)
NZ (1) NZ193730A (en)
OA (1) OA06533A (en)
PL (1) PL224313A1 (en)
PT (1) PT71251A (en)
ZA (1) ZA802909B (en)
ZW (1) ZW11880A1 (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4507146A (en) * 1982-12-28 1985-03-26 Ciba-Geigy Corporation 2,4-Diamino-6-halo-5-trifluoromethylpyrimidines having herbicidal activity
DE3829469A1 (en) * 1988-08-31 1990-03-01 Bayer Ag METHOD FOR THE PRODUCTION OF SUBSTITUTED N-AZINYL-N'-SULFONYL-ISOTHIO-UREAS AND N-AZINYL-IMINODITHIOCARBONIC ACID-S, S-DIESTER AS INTERMEDIATE PRODUCTS FOR THEIR PRODUCTION
CA2269971A1 (en) * 1997-09-03 1999-03-11 Trent Lee Abraham Pyrimidine derivatives
US7473691B2 (en) 2000-09-15 2009-01-06 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
US6660731B2 (en) 2000-09-15 2003-12-09 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
KR100876069B1 (en) 2000-09-15 2008-12-26 버텍스 파마슈티칼스 인코포레이티드 Pyrazole Compounds Useful as Protein Kinase Inhibitors and Pharmaceutical Compositions Comprising the Same
MXPA03005610A (en) 2000-12-21 2003-10-06 Vertex Pharma Pyrazole compounds useful as protein kinase inhibitors.
HUP0401858A3 (en) * 2001-01-31 2009-06-29 Lundbeck & Co As H Gal3 receptor antagonist pyrimidine and indolone-derivatives and their use for preparation of pharmaceutical compositions suitable for the treatment of depression and/or anxiety
US7229993B2 (en) 2002-03-13 2007-06-12 Euro-Celtique S.A. Aryl substituted pyrimidines and the use thereof
AU2003214110A1 (en) * 2002-03-15 2003-09-29 Ciba Specialty Chemicals Holding Inc. 4-aminopyrimidines and their use for the antimicrobial treatment of surfaces
US20040009981A1 (en) 2002-03-15 2004-01-15 David Bebbington Compositions useful as inhibitors of protein kinases
MY141867A (en) 2002-06-20 2010-07-16 Vertex Pharma Substituted pyrimidines useful as protein kinase inhibitors
MXPA05001367A (en) 2002-08-02 2005-04-28 Vertex Pharma Pyrazole compositions useful as inhibitors of gsk-3.
US7601718B2 (en) 2003-02-06 2009-10-13 Vertex Pharmaceuticals Incorporated Compositions useful as inhibitors of protein kinases
AU2006279376B2 (en) 2005-08-18 2011-04-14 Vertex Pharmaceuticals Incoporated Pyrazine kinase inhibitors
EP1951715B1 (en) 2005-11-03 2013-09-04 Vertex Pharmaceuticals Incorporated Aminopyrimidines useful as kinase inhibitors
ATE457311T1 (en) 2006-11-02 2010-02-15 Vertex Pharma AMINOPYRIDINES AND AMINOPYRIMIDINES SUITABLE AS INHIBITORS OF PROTEIN KINASES
DE602007007985D1 (en) 2006-12-19 2010-09-02 Vertex Pharma AS INHIBITORS OF PROTEIN KINASES SUITABLE AMINO-PRIMIDINES
MX2009009591A (en) 2007-03-09 2009-11-10 Vertex Pharma Aminopyrimidines useful as inhibitors of protein kinases.
CA2679701A1 (en) 2007-03-09 2008-09-18 Vertex Pharmaceuticals Incorporated Aminopyridines useful as inhibitors of protein kinases
ES2435997T3 (en) 2007-03-09 2013-12-26 Vertex Pharmaceuticals, Inc. Aminopyrimidines useful as protein kinase inhibitors
WO2008128009A2 (en) 2007-04-13 2008-10-23 Vertex Pharmaceuticals Incorporated Aminopyrimidines useful as kinase inhibitors
WO2008137621A1 (en) 2007-05-02 2008-11-13 Vertex Pharmaceuticals Incorporated Aminopyrimidines useful as kinase inhibitors
JP5389785B2 (en) 2007-05-02 2014-01-15 バーテックス ファーマシューティカルズ インコーポレイテッド Thiazoles and pyrazoles useful as kinase inhibitors
AU2008282156B2 (en) 2007-07-31 2014-07-17 Vertex Pharmaceuticals Incorporated Process for preparing 5-fluoro-1H-pyrazolo [3, 4-b] pyridin-3-amine and derivatives thereof
RU2011112802A (en) 2008-09-03 2012-10-10 Вертекс Фармасьютикалз Инкорпорейтед (Us) CO-CRYSTALS AND THEIR PHARMACEUTICAL COMPOSITIONS
AU2009333559B2 (en) * 2008-12-09 2015-03-12 Gilead Sciences, Inc. Modulators of toll-like receptors
KR102328682B1 (en) * 2018-08-27 2021-11-18 주식회사 대웅제약 Novel heterocyclicamine derivatives and pharmaceutical composition comprising the same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE754832A (en) * 1969-08-14 1971-02-15 Beecham Group Ltd IMINAZOLINES

Also Published As

Publication number Publication date
MA18829A1 (en) 1980-12-31
IL60086A (en) 1984-03-30
KR830002757A (en) 1983-05-30
PT71251A (en) 1980-06-01
ES491514A0 (en) 1981-04-16
AR228256A1 (en) 1983-02-15
PL224313A1 (en) 1981-02-13
GR68453B (en) 1981-12-30
IE801023L (en) 1980-11-18
NZ193730A (en) 1982-12-21
GB2052487B (en) 1983-05-11
ZA802909B (en) 1981-05-27
EP0019811A1 (en) 1980-12-10
JPS55154971A (en) 1980-12-02
OA06533A (en) 1981-07-31
ZW11880A1 (en) 1980-12-17
GB2052487A (en) 1981-01-28
NO801469L (en) 1980-11-19
DD150609A5 (en) 1981-09-09
IE49803B1 (en) 1985-12-25
AU5848480A (en) 1980-11-20
ES8104279A1 (en) 1981-04-16
FI801600A (en) 1980-11-19
IL60086A0 (en) 1980-07-31

Similar Documents

Publication Publication Date Title
DK214480A (en) PROCESS FOR THE PREPARATION OF 2- (PYRIMIDINYLAMINO) -1,3-DIAZA-2-CYCLOALKEN COMPOUNDS OF THEIR TAUTOMER COMPOUNDS AND ACID ADDITION SALTS THEREOF
DK462380A (en) METHOD OF ANALOGUE FOR THE PREPARATION OF 2,4-DIAMINOQUINAZOLINE COMPOUNDS OR ACID ADDITION SALTS.
DK178379A (en) PROCEDURE FOR THE PREPARATION OF N-SUBSTITUTED MORANOLIN DERIVATIVES OR ACID ADDITIONAL SALTS THEREOF
DK344280A (en) PROCEDURE FOR THE PREPARATION OF AMINOPROPOXYAR HORSE DERIVATIVES
DK45081A (en) PROCESS FOR THE PREPARATION OF 2- (2- (1,4-BENZODIOXANYL)) - IMIDAZOLINE OR NON-TOXIC ACID ADDITION SALTS.
DK493083D0 (en) PROCEDURE FOR THE PREPARATION OF 4-OXO-1,4-DIHYDE PROCESS FOR THE PREPARATION OF 4-OXO-1,4-DIHYDRONICOTINIC ACID DERIVATIVES OR SALTS THEREOF RONICOTINIC ACID DERIVATIVES OR SALES
DK325078A (en) PROCEDURE FOR THE PREPARATION OF 5-SUBSTITUTED-1,2-DIHYDRO-3H-PYRROLO (1,2A) -PYRROL-1-CARBOXYLIC ACIDS OF THEIR CORRESPONDING NITRILES
DK163580C (en) METHOD OF ANALOGY FOR THE PREPARATION OF CYCLOHEXANCARBOXYLIC ACID DERIVATIVES
DK320680A (en) PROCEDURE FOR THE PREPARATION OF FLUORED BETA-ALANINE DERIVATIVES
DK134580A (en) PROCEDURE FOR THE PREPARATION OF 2,6-DIAMINONEBULARIN OR ACID ADDITION SALTS THEREOF
DK365980A (en) PROCEDURE FOR PREPARING 7-BETAAMINOTHIADIAZOLYLACETYLAMINO-3-CEPHEM-4-CARBOXYLIC ACID COMPOUNDS OR SALTS THEREOF
DK152754C (en) METHOD OF ANALOGUE FOR THE PREPARATION OF 1-ACYL-8- (3-AMINO-2-HYDROXYPROPOXY) -1,2,3,4-TETRAHYDROQUINOLINES OR PHARMACEUTICAL ACCEPTABLE ACID ADDITION SALTS.
DK289080A (en) PROCESS FOR DIVOLUTION OF D, 1 2- (6-METHOXY2-NAPHTHYL) PROPIONIC ACID
DK172479A (en) PROCEDURE FOR THE PREPARATION OF N-ALKENYL MORANOLINE DERIVATIVES OR ACID ADDITIONAL SALTS THEREOF
DK455980A (en) METHOD OF ANALOGUE FOR THE PREPARATION OF SPIROIMIDAZOLONE COMPOUNDS OR ACID ADDITION SALTS
DK516480A (en) PROCESS FOR THE PREPARATION OF 2-AMINO-ETHANOL DERIVATIVES OR ACID ADDITION SALTS.
DK234182A (en) PROCEDURE FOR PREPARING HETEROCYCLIC SUBSTITUTED AMIDOXIMES OR ACID ADDITION SALTS.
DK229580A (en) PROCEDURE FOR THE PREPARATION OF GUANIDINE DERIVATIVES THEIR TAUTOMER COMPOUNDS AND SALTS
DK258180A (en) PROCEDURE FOR THE PREPARATION OF PYRIDYLAMINOTRIAZOLES OR ACID ADDITION SALTS.
DK146537C (en) METHOD OF ANALOGUE FOR THE PREPARATION OF SPIRO-QUINOLON HYDANTOIN COMPOUNDS OR ACID ADDITION SALTS
DK154880A (en) PROCEDURE FOR PREPARING DERIVATIVES OF 6BETA-AMIDINOPENICILLANIC ACID
DK129380A (en) PROCEDURE FOR PREPARING 6,7-DIALCOXY-1-PIPERIDINOPHTHALAZINE COMPOUNDS OR ACID ADDITION SALTS.
DK509780A (en) PROCEDURE FOR THE PREPARATION OF ANTI-TUMORACTIVE SALTS
DK198280A (en) PROCESS FOR THE PREPARATION OF 6- (SUBSTITUTED AMINO) -3-PYRIDAZINYL HYDRAZINES OR SALTS THEREOF
DK5880A (en) METHOD OF ANALOGUE FOR THE PREPARATION OF N, N-DI (N-ALKYL) AMINOMETHYLPHENYLETHANOLAMINES OR ACID ADDITION SALTS THEREOF

Legal Events

Date Code Title Description
ATS Application withdrawn
AHS Application shelved for other reasons than non-payment